Biopolym. Cell. 2025; 41(4):275.
http://dx.doi.org/10.7124/bc.000B27
Molecular Biomedicine
Establishment of U-251 MG cell sublines with ectopic overexpression of CHI3L1 mRNA variants as a model system of the isoforms trials in gliomagenesis
1, 2Areshkov P. O., 1Anopriienko O. V., 1Shloma A. R., 1Solomiana K. I., 1, 2Zhuk O. V., 1, 2Bukreieva T. V., 2, 3, 4Rybachuk O. A., 3Nesterenko Yu. A., 1, 2Skrypkina I. Ya.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03143
  2. Institute of Cell Therapy
    3, Liubomyra Huzara Ave., Kyiv, Ukraine, 03126
  3. O.O. Bogomoletz Institute of Physiology, NAS of Ukraine
    4, Akademika Bohomoltsia Str., Kyiv, Ukraine, 01024
  4. Institute of Genetic and Regenerative Medicine,
    M.D. Strazhesko National Scientific Center of Cardiology,
    Clinical and Regenerative Medicine, NAMS of Ukraine
    5, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03151

Abstract

Aim. Obtaining glioma derived U-251 MG cell sublines producing the full-length and the short variants of CHI3L1 with subsequent characterization. Methods. Cell lentiviral transduction, Western blot and RT-qPCR analysis. Results. We successfully generated the U-251 MG cell sublines producing the full-length and the short variants of CHI3L1; our results support the suppression of CHI3L1-del8ex secretion and demonstrate differential targeting of microenvironment (LOX and GUSB) and EMT program (TGFB1) modulators by CHI3L1 isoforms. Conclusion. Here we present the cell model for CHI3L1 isoforms trials in gliomagenesis regarding experiments on co-cultivation and/with 3D culturing.
Keywords: CHI3L1, glioblastoma, transcriptional isoforms, splicing, differentially expressing genes (DEG), epithelial-mesenchymal transition (EMT)
Full text: (PDF, in English)

References

[1] Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev. 2006; 15(2):194-202.
[2] Yu JE, Yeo IJ, Han SB, Yun J, Kim B, Yong YJ, Lim YS, Kim TH, Son DJ, Hong JT. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med. 2024; 56(1):1-18.
[3] Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020; 5(1):201.
[4] Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002; 365(Pt 1):119-26.
[5] Stark R, Grzelak M, Hadfield J. RNA sequencing: the teenage years. Nat Rev Genet. 2019; 20(11):631-56.
[6] Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem. 2007; 55(12):1213-28.
[7] Shi M, Ge Q, Wang X, Diao W, Yang B, Sun S, Wang G, Liu T, Chan AM, Gao Z, Wang Y, Wang Y. Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma. Front Oncol. 2022; 12:910728.
[8] Ren Y, Huang Z, Zhou L, Xiao P, Song J, He P, Xie C, Zhou R, Li M, Dong X, Mao Q, You C, Xu J, Liu Y, Lan Z, Zhang T, Gan Q, Yang Y, Chen T, Huang B, Yang X, Xiao A, Ou Y, Su Z, Chen L, Zhang Y, Ju Y, Zhang Y, Wang Y. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. Nat Commun. 2023; 14(1):1028.
[9] Anopriyenko OV, Areshkov PO, Zhuk OV, Shablii VA, Skrypkina IYa. Integral Regulation Of CHI3L1 Gene And ERVW-1 Locus Expression By Heparin In The Gioblastoma Cell Lines U-87 MG And U-251 MG. Factors Exp Evol Org. 2019; 25:101-5.
[10] Jung H, Kim YE, Kim EM, Kim KK. Alternative splicing of CHI3L1 regulates protein secretion through conformational changes. Genes Genomics. 2025; 47(5):571-9.
[11] Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997; 15(9):871-5.
[12] Svitina H, Skrypkina I, Areshkov P, Kyryk V, Bukreieva T, Klymenko P, Garmanchuk L, Lobintseva G, Shablii V. Transplantation of placenta-derived multipotent cells in rats with dimethylhydrazine-induced colon cancer decreases survival rate. Oncol Lett. 2018; 15(4):5034-42.
[13] Lu D, Lin Z, Wang R, Chen Z, Zhuo J, Xu L, Pan L, Li H, Yang X, He C, Shen W, Yang M, Li H, Chen H, Tan W, Wei X, Zheng S, Xu X. Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer. Redox Biol. 2022; 58:102538.